863
Views
0
CrossRef citations to date
0
Altmetric
Reports

Anti-recoverin antibody positive Heidenhain variant CJD: a case report

ORCID Icon, ORCID Icon &
Pages 133-137 | Received 03 Apr 2023, Accepted 06 Jun 2023, Published online: 19 Jun 2023

References

  • Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(Pt 10):2659–2668. doi: 10.1093/brain/awp191
  • Krasnianski A, Kaune J, Jung K, et al. First symptom and initial diagnosis in sporadic CJD patients in Germany. J Neurol. 2014;261(9):1811–1817. doi: 10.1007/s00415-014-7410-z
  • Baiardi S, Capellari S, Ladogana A, et al. Revisiting the Heidenhain variant of Creutzfeldt-Jakob disease: evidence for prion type variability influencing clinical course and laboratory findings. J Alzheimers Dis. 2016;50(2):465–476. doi: 10.3233/JAD-150668
  • Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M, et al. The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol. 1999;56(1):55–61. doi:10.1001/archneur.56.1.55
  • Katz BJ, Warner JE, Digre KB, et al. Selective loss of the electroretinogram B-wave in a patient with Creutzfeldt-Jakob disease. J Neuroophthalmol. 2000;20(2):116–118. doi: 10.1097/00041327-200020020-00011
  • Armstrong RA. Creutzfeldt-Jakob disease and vision. Clin Exp Optom. 2006;89(1):3–9. doi: 10.1111/j.1444-0938.2006.00001.x
  • Cooper SA, Murray KL, Heath CA, et al. Isolated visual symptoms at onset in sporadic Creutzfeldt-Jakob disease: the clinical phenotype of the “Heidenhain variant”. Br J Ophthalmol. 2005;89(10):1341–1342. doi: 10.1136/bjo.2005.074856
  • Bazhin AV, Schadendorf D, Philippov PP, et al. Recovering as a cancer-retina antigen. Cancer Immunol Immunother. 2007;56(1):110–116. doi: 10.1007/s00262-006-0132-z
  • Shimazaki K, Jirawuthiworavong GV, Heckenlively JR, et al. Frequency of anti-retinal antibodies in normal human serum. J Neuro ophthalmol. 2008;28(1):5–11. doi: 10.1097/WNO.0b013e318167549f
  • Shiraga S, Adamus G. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol. 2002;132(1–2):72–82. doi: 10.1016/S0165-5728(02)00314-4
  • Sakuma T, Watanabe S, Ouchi A, et al. Three cases of Creutzfeldt-Jakob disease with visual disturbances as initial manifestation. Case Rep Ophthalmol. 2019;10(3):349–356. doi: 10.1159/000503274
  • Urriola N, Soosapilla K, Herkes G, et al. Heidenhain variant sporadic Creutzfeldt-Jakob disease diagnosed as an autoimmune encephalitis due to a false-positive GAD autoantibody. BMJ Case Rep. 2019;12(5):e229018. doi: 10.1136/bcr-2018-229018